Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib cream in non-segmental vitiligo (TRuE-V2)
NCT04057573Phase 3Completed
- Sponsor
- Incyte
- Start
- Oct 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of ruxolitinib cream in Vitiligo, sponsored by Incyte. Started Oct 2019; status: completed.
02
Drugs
ruxolitinib cream
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04057573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04057573.